A Phase III Study Comparing Mometasone Furoate with Eucerin to Treat Radiation-Related Skin Redness and Peeling in Breast Cancer Patients after Mastectomy

Protocol
13-069
Full Title
Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation:A Randomized Trial, Double Blind Trial
Phase
III
Purpose

Irritation of the skin is a common side effect of radiation therapy. Eucerin is an over-the-counter lotion often recommended for women who are receiving radiation therapy for breast cancer, to prevent the treated skin from becoming dry or peeling. In this study, researchers want to compare the effectiveness of a prescription steroid cream called mometasone furoate with Eucerin for the treatment of skin irritation in women receiving radiation therapy after mastectomy. Mometasone furoate is used to treat skin redness and irritation by reducing skin inflammation.

Women in this study will be randomly assigned to receive Eucerin or mometasone furoate cream, but not both, and researchers will compare the two groups.

Investigator
Olm-Shipman, Molly, RN
Eligibility

This study includes adult women who are receiving radiation therapy after having a mastectomy for stage I-III breast cancer.

For more information about this study, please contact Molly Olm-Shipman, RN, at 212-639-6773.

Disease(s)
Breast Cancer
Related Diseases